---
title: "JENKEM established a life sciences technology company in Hainan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235959362.md"
description: "According to the Qichacha APP, recently, Hainan JENKEM Life Science Technology Co., Ltd. was established, with Wang Chen as the legal representative and a registered capital of 50 million yuan. The business scope includes: research and development of biochemistry products technology; engineering and technology research and experimental development. Qichacha's equity penetration shows that the company is wholly owned by JENKEM"
datetime: "2025-04-15T02:17:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235959362.md)
  - [en](https://longbridge.com/en/news/235959362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235959362.md)
generator: "portal-rs"
---

# JENKEM established a life sciences technology company in Hainan

According to the Qichacha APP, recently, Hainan JENKEM Life Science Technology Co., Ltd. was established, with Wang Chen as the legal representative and a registered capital of 50 million yuan. The business scope includes: research and development of biochemistry products technology; engineering and technology research and experimental development. Qichacha's equity penetration shows that the company is wholly owned by JENKEM

### Related Stocks

- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [12:25 ETAce Pickleball Club Media Launches Beyond The Bounce Digital Magazine and Opens Investment Opportunity to the Public](https://longbridge.com/en/news/296638710.md)
- [Jiangsu Expressway schedules interim results presentation via telephone video conference](https://longbridge.com/en/news/296498702.md)
- [03:20 ETMacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology](https://longbridge.com/en/news/296749870.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**